Investors have been led astray by misleading signals from the market. It enticed them to go “all in” on centralized exchanges rather than focusing on real-world use cases for tokenized value exchange.Consensus MagazineRead More

You might also be interested in reading Kyverna Therapeutics GAAP EPS of -$1.03.